SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maakamil who wrote (10249)11/12/1998 10:14:00 AM
From: Lane Hall-Witt  Read Replies (3) of 119973
 
Funny thing is, for a R&D biotech firm like ALLP, increased losses can actually be a good sign since it indicates that they're ramping up for testing. ALLP holds more than 50 patents (most recent one issued Nov. 3), has one product already in Phase III, and has two more products about to enter Phase III. (Getting Phase III approval is extremely rare: according to the ALLP Web site, only 1 of 1,000 compounds that enter preclinical testing even make it to Phase I.)

More than one-third of the company's shares are held by institutions.

A few references for DD:

allp.com
uspto.gov
fda.gov
marketguide.com

I think the early selling came from yesterday's short-term traders and from those spooked by ENMD.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext